Prasol Chemicals

Established in 1992, Prasol Chemicals has evolved over three decades into a significant player in the specialty chemicals landscape. The company focuses on high-complexity chemistry, specializing in the manufacture of acetone-based and phosphorus-based chemicals to serve a broad industrial base.

Their expansive product portfolio consists of 150 specialty chemicals, categorized into 21 acetone-based, 53 phosphorus-based, and 76 other complex chemicals. This diversification allows them to cater to multiple critical sectors including paints, inks, construction, adhesives (PICA), and home and personal care.

The company maintains a strong market position with a global footprint, exporting its products to 69 countries and serving a vast client base of 1,600 customers. Key prestigious clients include industry leaders such as Alembic Pharmaceuticals, Lubrizol India, Rossari Biotech, and Clean Science.

Operationally, Prasol Chemicals leverages two large-scale manufacturing facilities located in Khopoli and Mahad, Maharashtra, with land parcels of approximately 1.20 lakh sq. m. each. This infrastructure supports their capacity to produce high-volume specialty reagents.

The promoter group is led by Nishith Rajnikant Shah and Gaurang Natwarlal Parikh, along with several other family and business associates. Their collective leadership has steered the company from a domestic manufacturer to an international exporter.

Prasol Chemicals is launching a Mainboard IPO to raise approximately ₹500 crore. The issue is structured with a fresh issue of ₹80 crore and a substantial Offer for Sale (OFS) of approximately 62.13 lakh shares, meaning 84% of the issue is promoter offloading. The price band is set between ₹643 to ₹676 per share, with a minimum lot size of 22 shares (₹14,872).

The proceeds from the fresh issue are primarily earmarked for the repayment or prepayment of certain borrowings, amounting to ₹60 crore, which will further lean out the balance sheet.

Financial performance has shown an impressive upward trajectory. Revenue grew from ₹887.56 crore in FY24 to ₹1,237.85 crore in FY26. Even more notable is the profit growth, with PAT surging from ₹18.13 crore in FY24 to ₹83.12 crore in FY26, indicating significant operating leverage.

From a valuation perspective, the company boasts a healthy ROE of 20.37% and ROCE of 22.43%. While the P/E is not explicitly provided, the EPS of ₹14.33 suggests a competitive pricing strategy when compared to peers like Aarti Industries and Vinati Organics, though the high OFS component is a point of caution.

Investment strengths include a diversified product portfolio, an established global export network, and a very low debt-to-equity ratio of 0.19. The company's ability to scale profits faster than revenues is a key highlight for growth investors.

However, risks include the high proportion of OFS, which may be perceived as promoters exiting at a peak valuation. Additionally, the specialty chemicals sector is subject to raw material price volatility and stringent environmental regulations. Investors should balance the strong growth metrics against the structural issue of promoter offloading.